Research Overview
Figure 1. Overview of (high-fat-high-sugar diet) HFHSD combined with streptozotocin (STZ) to induce type II diabetes model. 8-12 weeks marked the experimental period, where mice were randomly divided into 5-8 groups (10-12 mice per group).
Data Validation
1. Body Weight Curve
Figure 2. Obesity phenotype was not observed in model group after STZ injection. Data are presented as Mean±SEM. n=5-50.
Efficacy Data
1. Blood Glucose Levels and HbA1c
Figure 3. Test drug significantly reduced the fasting blood glucose and HbA1c levels. Statistical analysis by two-tailed unpaired t test, data are presented as Mean±SEM, n=5-10. ****, P<0.0001.
2. Glucose Tolerance Test
Figure 4. Test drug significantly improved the glucose intolerance of diabetic mice. Statistical analysis by one way ANOVA with Tukey’s post hoc test, data are presented as Mean±SEM. n=5-10. ****, P<0.0001.